Quantifying the impact of COVID-19-related restrictions on antibiotic resistance

Clin Microbiol Infect. 2024 Oct;30(10):1225-1227. doi: 10.1016/j.cmi.2024.07.007. Epub 2024 Jul 11.

Authors

Charis A Marwick¹, Laura Ciaccio²

Affiliations

¹ Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom. Electronic address: c.z.marwick@dundee.ac.uk.
² Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.

PMID: 39002662
DOI: 10.1016/j.cmi.2024.07.007

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
COVID-19* / epidemiology
Drug Resistance, Bacterial
Humans
SARS-CoV-2 / drug effects

Substances

Anti-Bacterial Agents